Preliminary reports indicate conolidine could inhibit specific ion channels, cutting down neuronal excitability and limiting ache alerts. This system is particularly suitable in neuropathic suffering, exactly where irregular signaling results in persistent discomfort. Also, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integ